Identification of second-site mutations that enhance release and spread of vaccinia virus.
about
A36-dependent actin filament nucleation promotes release of vaccinia virusThe Structure of the Poxvirus A33 Protein Reveals a Dimer of Unique C-Type Lectin-Like DomainsNef from pathogenic simian immunodeficiency virus is a negative factor for vaccinia virus.Molecular characterization and phylogenetics of Fennoscandian cowpox virus isolates based on the p4c and atip genes.In vitro host range, multiplication and virion forms of recombinant viruses obtained from co-infection in vitro with a vaccinia-vectored influenza vaccine and a naturally occurring cowpox virus isolate.Evolution of vaccinia virus-specific CD8+ cytotoxic T-lymphocyte responses in primary vaccinees and revaccinees.The A33-dependent incorporation of B5 into extracellular enveloped vaccinia virions is mediated through an interaction between their lumenal domainsVaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challengeMutations in the vaccinia virus A33R and B5R envelope proteins that enhance release of extracellular virions and eliminate formation of actin-containing microvilli without preventing tyrosine phosphorylation of the A36R protein.Poxvirus proteomics and virus-host protein interactions.The non-canonical roles of clathrin and actin in pathogen internalization, egress and spread.Vaccinia virus A34 glycoprotein determines the protein composition of the extracellular virus envelope.Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara.A genotype of modified vaccinia Ankara (MVA) that facilitates replication in suspension cultures in chemically defined medium.Interaction between vaccinia virus extracellular virus envelope A33 and B5 glycoproteins.Suppression of NYVAC Infection in HeLa Cells Requires RNase L but Is Independent of Protein Kinase R Activity.Complete Genome Sequence of a UL96 Mutant Cytomegalovirus Towne-BAC (Bacterial Artificial Chromosome) Isolate Passaged in Fibroblasts To Allow Accumulation of Compensatory MutationsProtein B5 is required on extracellular enveloped vaccinia virus for repulsion of superinfecting virions.CRISPR/Cas9-Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development.Loss of Actin-Based Motility Impairs Ectromelia Virus Release In Vitro but Is Not Critical to Spread In Vivo.
P2860
Q27335617-E3C882ED-4E97-4322-88C3-5DBC82AA04EAQ27658759-F094D277-3CAA-416F-A55A-70F9FD0D0E8CQ33840818-6D4E2349-B870-4260-A82B-C4D8FE083620Q33959238-25F609AC-76E2-45AA-8FC5-7B2F7D23323AQ34017475-E996497A-C58E-4D39-9ADE-3FDCB6387A47Q35522651-50B86D6D-9FF8-42A9-B42A-85A8A3193B63Q36171927-0E46417F-9BB7-4116-ABA7-6FC3499255EDQ36498244-3D699D54-4CDF-4C0B-9963-0E9312BA3CE2Q36890237-337AAE7C-51E5-49C3-A56B-0E3537C55F17Q37640977-24628AEF-78D9-44A7-9F76-18E2ECEF7911Q38135838-4B019D3E-1A6F-4770-AD11-E12AB6C11E3FQ38295116-0D3A023F-4B50-4806-99EB-00538781F37EQ38970262-3600F3B7-908A-4CDD-8D47-AF71676289E6Q39207337-5A251CAB-7932-44F5-AE2D-BA39234003B1Q40243102-26A79FEF-774C-4B0E-8E79-5C75BE027248Q40875488-11E7B1C3-EFA2-4169-BA11-E3EFAB10AF31Q41984428-CF8D5294-3002-4275-A82E-4BC7113E7FABQ42108903-A053E715-6D05-49A0-8703-5A459CFF08D8Q47549689-95F42941-2A11-4B82-83A9-408FFD7B081CQ52365425-43948333-67CD-4068-9337-87F6345B0CAB
P2860
Identification of second-site mutations that enhance release and spread of vaccinia virus.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Identification of second-site ...... and spread of vaccinia virus.
@ast
Identification of second-site ...... and spread of vaccinia virus.
@en
Identification of second-site ...... and spread of vaccinia virus.
@nl
type
label
Identification of second-site ...... and spread of vaccinia virus.
@ast
Identification of second-site ...... and spread of vaccinia virus.
@en
Identification of second-site ...... and spread of vaccinia virus.
@nl
prefLabel
Identification of second-site ...... and spread of vaccinia virus.
@ast
Identification of second-site ...... and spread of vaccinia virus.
@en
Identification of second-site ...... and spread of vaccinia virus.
@nl
P2860
P1433
P1476
Identification of second-site ...... and spread of vaccinia virus.
@en
P2093
Elizabeth Wolffe
P2860
P304
11637-11644
P356
10.1128/JVI.76.22.11637-11644.2002
P407
P50
P577
2002-11-01T00:00:00Z